Emerging Infectious Disease ISSN: 1080-6059

Mycobacterium haemophilum Infection after Alemtuzumab Treatment

Mini Kamboj

, Eddie Louie, Timothy Kiehn, Genovefa Papanicolaou, Michael Glickman, and Kent Sepkowitz

Author affiliations: Memorial Sloan-Kettering Cancer Center, New York, New York, USA (M. Kamboj, T. Kiehn, G. Papanicolaou, M. Glickman, K. Sepkowitz); New York University, New York (E. Louie);

Main Article

Figure

Nodular-ulcerative skin lesions on the left thigh caused by Mycobacterium haemophilum infection in a patient with chronic lymphocytic leukemia (patient 1) whose condition had been treated with alemtuzumab.

Figure. Nodular-ulcerative skin lesions on the left thigh caused by Mycobacterium haemophilum infection in a patient with chronic lymphocytic leukemia (patient 1) whose condition had been treated with alemtuzumab.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.